NeOnc Technologies Holdings, Inc. Common Stock (NASDAQ: NTHI) — Healthcare · Share Price, Chart & Market Data
About: NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.87 (+1.88%)
NTHINeOnc Technologies Holdings, Inc. Common Stock
Loading watchlist status…
Trade NTHI now
NeOnc Technologies Holdings, Inc. Common Stock share price
NTHI price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 4:57 pm GMT+0
NTHI price performance
-5.068%
5D
-33.012%
1M
-45.158%
YTD
-18.698%
1Y
NTHI price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 4:57 pm GMT+0
NTHI details
NTHI Market Signals